VANTIVE US HEALTHCARE LLC

Lobbying for VANTIVE US HEALTHCARE LLC · Medical Technology Manufacturing

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Expenses

$390,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 8

Centers For Medicare and Medicaid Services (CMS)
Commerce, Dept of (DOC)
Executive Office of the President (EOP)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
Intl Trade Administration (ITA)
SENATE
State, Dept of (DOS)

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 2

HR 8319
KIDNEY Remote Monitoring Act
HR 4441
Patient Access to Innovative New Technologies Act of 2025

Lobbying activity 4

Trade (domestic/foreign)

Issues related to tariffs including issues related to Section 232 investigation of medical devices. Issues related to medical technology trade.

Medicare/Medicaid

Issues related to ESRD reimbursement H.R. 8319 - KIDNEY Remote Monitoring Act, Issues related to physician reimbursement for remote patient monitoring. H.R. 4441 - Patient Access to Innovative New Technologies Act, Issues related to sepsis device breakthrough designation.

Health Issues

Issues related to ESRD reimbursement H.R. 8319 - KIDNEY Remote Monitoring Act, Issues related to physician reimbursement for remote patient monitoring

Foreign Relations

Issues related to U.S. global health program priorities

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.